According to the mechanistic studies, formononetin is able to inhibit the growth of colon cancer cells by downregulating the expression of the cell cycle-associated protein (cyclin D1) and causing cell cycle arrest at the G0/G1 checkpoint. Here, CCND1 is linked to malignant colon neoplasm.